Autres langues Crossject

Actions

ALCJ

FR0011716265

Equipement, fournitures et distribution médicale

Marché Fermé - Euronext Paris 17:55:00 25/09/2026			Varia. 5j.	Varia. 1 janv.
1,336 ^EUR	+0,45%		+0,75%	-39,00%

25/09	Crossject : H126. Quoi de neuf sous le soleil ? Pas grand-chose.	AL
25/09	Crossject Société Anonyme publie ses résultats pour le semestre clos le 30 juin 2026	CI

Autres langues

25/09	Crossject : H126. Quid novi sub sole? Not much.
25/09	CROSSJECT : Reports Its First-Half 2026 results
25/09	Crossject Société Anonyme Reports Earnings Results for the Half Year Ended June 30, 2026
25/09	Crossject Société Anonyme Announces Executive Board Appointments, Effective September 25, 2026
25/09	CROSSJECT Reports Its First-Half 2026 Results and Presents a Significantly Strengthened Financial Structure
25/09	CROSSJECT strengthens its governance for the industrial and commercial deployment phase
23/09	CROSSJECT and BARDA align ZEPIZURE®’s Pediatric development plan with FDA including funding through 2030
23/09	CROSSJECT Aligns ZEPIZURE Pediatric Development Plan With BARDA And FDA
26/05	Crossject : The last round of financing?
22/05	Crossject Raises EUR15 Million Via Placing of Shares, Warrants
22/05	CROSSJECT announces the successful completion of an equity financing and warrant issuance for a total immediate gross amount of €15 million
30/04	MISE A DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025
30/03	Crossject : Integrating the FY25 numbers
26/03	Crossject Names New Finance Chief
25/03	CROSSJECT appoints Lionel Seltz as Chief Financial Officer
25/03	Crossject Appoints Lionel Seltz as Chief Financial Officer
25/03	Crossject : FY25 results: no big change.
25/03	Crossject Société Anonyme Reports Earnings Results for the Full Year Ended December 31, 2025
25/03	CROSSJECT publishes its 2025 financial results and confirms the strengthening of its operational, industrial and financial trajectory
02/02	CROSSJECT announces initiation of coverage of its stock by Portzamparc (BNP Paribas Group)
17/11	Crossject : Yet another round of financing
17/11	Crossject Raises EUR5 Million Via Convertible Bonds Issuance
14/11	CROSSJECT completes €5 million financing with Vatel Capital
14/11	Crossject Société Anonyme announced that it has received ?5 million in funding
24/09/25	CROSSJECT presents its financial results and key highlights for the first half of 2025